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Red Blood Cell Distribution Width, Hematology, and Serum
Biochemistry in Dogs with Echocardiographically Estimated
Precapil lary and Postcapil lary Pulmonary Arterial Hypertension
E. Mazzotta, C. Guglielmini, G. Menciotti, B. Contiero, M. BaronToaldo, M. Berlanda, and H. Poser
Background: Red blood cell distribution width (RDW) is a quantitative measurement of anisocytosis. RDW has prognos-
tic value in humans with diﬀerent cardiovascular and systemic disorders, but few studies have investigated this biomarker in
dogs.
Objectives: To compare the RDW in dogs with precapillary and postcapillary pulmonary hypertension (PH) and a
control population of dogs and to correlate RDW with demographic, echocardiographic, and laboratory variables.
Animals: One hundred and twenty-seven client-owned dogs including 19 healthy dogs, 82 dogs with myxomatous mitral
valve disease (50 dogs without PH and 32 dogs with postcapillary PH), and 26 dogs with precapillary PH.
Methods: Prospective study. Dogs were allocated to groups according to clinical and echocardiographic evaluation. RDW
and selected laboratory and echocardiographic variables were compared among dog groups. Associations between RDW and
demographic, laboratory, and echocardiographic variables were analyzed using correlation and multiple regression analysis.
Results: Median RDW in dogs with precapillary PH (13.8%, interquartile range 13.2–14.9%) and postcapillary PH (13.7,
13.2–14.7%) was signiﬁcantly increased compared to healthy dogs (13.3, 12.3–13.7%; P < .05 for both comparisons), but
only dogs with severe PH had signiﬁcantly increased RDW compared to dogs without PH (P < .05). Peak tricuspid regurgita-
tion pressure gradient was signiﬁcantly associated with increased RDW (rho = 0.263, P = .007). Serum urea concentration,
hematocrit, age, and white blood cell number were signiﬁcantly associated with RDW in the multivariate analysis.
Conclusions and Clinical Importance: Underlying pathophysiologic processes associated with PH instead of severity of PH
are likely responsible for increased RDW in dogs with PH.
Key words: Azotemia; Canine; Cardiac biomarker; Cardiovascular disease; Echocardiography.
Red blood cell distribution width (RDW) is a mea-surement of the size variation as well as an index
of the heterogeneity of the circulating erythrocytes.1–3
The RDW is a component of a CBC and is automati-
cally calculated by modern cell counters by dividing the
standard deviation of erythrocyte volume by the mean
corpuscular volume (MCV).4 Evaluation of RDW, in
combination with MCV, is conventionally used in the
diﬀerential diagnosis of anemia and has been tradition-
ally employed to discriminate between regenerative and
nonregenerative anemia in the dog.1,2 A high value of
RDW was identiﬁed as a negative prognostic indicator
in humans with diﬀerent cardiovascular and thrombotic
disorders, including pulmonary arterial hypertension5,6
and pulmonary embolism.7 The value of RDW in dogs
with myxomatous mitral valve disease (MMVD) and
compensated and decompensated heart failure has been
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Ao aortic diameter
BW body weight
cTnI cardiac troponin I
E-max transmitral early diastolic velocity
FS fractional shortening
LA:Ao left atrium to aortic diameter
LA left atrial diameter
LVDD left ventricular diastolic diameter
LVDDn left ventricular diastolic diameter normalized for body
weight
LVSD left ventricular systolic diameter
LVSDn left ventricular systolic diameter normalized for body
weight
MCV mean corpuscular volume
MMVD myxomatous mitral valve disease
PH-MMVD pulmonary hypertension associated with myxomatous
mitral valve disease
PH pulmonary hypertension
PIPG pulmonic insuﬃciency pressure gradient
PTE pulmonary thromboembolism
RDW red blood cell distribution width
TR Vmax peak tricuspid regurgitation velocity
TRPG tricuspid regurgitation pressure gradient
TR tricuspid regurgitation
WBC white blood cell number
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recently investigated, and it was neither associated with
disease severity nor to heart failure.8
Pulmonary hypertension (PH) refers to an increase in
pulmonary artery pressure that is usually secondary to
various cardiovascular, respiratory, or systemic diseases
in dogs.9,10 In humans, 5 types of PH are recognized
according to the underlying pathophysiological mecha-
nism.11 A more simpliﬁed classiﬁcation commonly
employed in dogs distinguishes precapillary PH from
postcapillary PH, the latter being PH associated with
left-sided cardiac diseases.9,10 The diagnosis of PH can
be accurately obtained by direct pulmonary pressure
measurement via cardiac catheterization, but this tech-
nique is invasive and rarely performed in the clinical
canine practice.12,13 Noninvasive estimation of pul-
monary artery systolic and diastolic pressure may be
obtained by Doppler echocardiography.10,12,14
Diﬀerent circulating markers of cardiovascular dam-
age have been investigated in dogs with PH, including
cardiac troponins and natriuretic peptides.14–16 In a
recent retrospective study, an increased RDW was
found in a group of dogs with PH of diﬀerent etiologies
compared to control dogs but no information has been
provided on the mechanism underlying this increase.17
Red blood cell distribution width is routinely included
in the clinical work up of dogs and is therefore a cost-
eﬀective variable compared to other more expensive car-
diac biomarkers. Although 2 recent retrospective studies
have investigated the RDW in dogs with diﬀerent car-
diovascular disorders,8,17 more information about the
eﬀect of PH or underling diseases on RDW may better
clarify its clinical usefulness. The aim of this study was
to compare RDW between dogs with echocardiographi-
cally estimated precapillary and postcapillary PH and a
control population and to determine whether RDW is
correlated with clinical, laboratory, and echocardio-
graphic variables.
Materials and Methods
Animals
The protocol of this prospective study was approved by the
Ethics Committee of the University of Padua. Client-owned dogs
presented to the cardiology service of the Veterinary Teaching
Hospital of the University of Padua from January 2013 to Novem-
ber 2015 were eligible for entering the study. During the same time
period, healthy dogs owned by students were also enrolled. After
the owner signed a written consent form, each dog underwent
physical examination, ECG, thoracic radiography, echocardio-
graphic examination (two-dimensional real time, M-mode, and
echo-Doppler), and blood sampling for CBC and serum biochemi-
cal proﬁle. A single investigator (CG) evaluated both the thoracic
radiographs and echocardiograms. Based on results of these exam-
inations, dogs were assigned to the diﬀerent groups according to
the following criteria:
(1) Clinically healthy dogs (control group): dogs with normal
physical examination and unremarkable ECG, thoracic
radiography, echocardiographic, echo-Doppler, CBC, and
serum biochemical proﬁle ﬁndings.
(2) Dogs with MMVD without PH (MMVD group): dogs with
an audible systolic murmur; thickened mitral valve leaﬂets
on two-dimensional echocardiography; mild-to-severe mitral
valve regurgitation; and low velocity tricuspid regurgitation
(TR) (i.e., <2.8 m/s, corresponding to a peak tricuspid
regurgitation pressure gradient [TRPG] <31 mmHg), end-
diastolic pulmonic insuﬃciency, or both (i.e., <2.2 m/s, cor-
responding to a pulmonic insuﬃciency pressure gradient
[PIPG] <19 mmHg) on spectral Doppler interrogation.
Dogs with MMVD but without detectable TR, pulmonic
insuﬃciency, or both were excluded from the study.
(3) Postcapillary PH associated with MMVD (PH-MMVD
group): dogs with an audible systolic murmur; thickened
mitral valve leaﬂets on two-dimensional echocardiography;
moderate-to-severe mitral valve regurgitation associated with
left atrial enlargement (LA:Ao ≥1.6); peak TR velocity (TR
Vmax) ≥2.8 m/s (TRPG ≥31 mmHg), end-diastolic pulmonic
insuﬃciency ≥2.2 m/s (PIPG ≥19 mmHg), or both without
echocardiographic and echo-Doppler evidence of right ven-
tricular outﬂow obstruction; and high transmitral early dias-
tolic ﬂow velocity (E-max>1.2 m/s) on Doppler
echocardiography. Dogs with PH-MMVD and other diseases
potentially associated with precapillary PH (e.g., overt respi-
ratory disease, heartworm disease, or hyperadrenocorticism)
were excluded from the study.
(4) Precapillary PH (precapillary PH group): dogs with clinical
signs of dyspnea, tachypnea, syncope, ascites, lethargy, or
exercise intolerance and a right-sided systolic murmur; and
peak TR Vmax ≥ 2.8 m/s (TRPG ≥ 31 mmHg), end-diasto-
lic pulmonic insuﬃciency ≥2.2 m/s (PIPG ≥ 19 mmHg), or
both on spectral Doppler echocardiography without echocar-
diographic and echo-Doppler evidence of right ventricular
outﬂow obstruction and other congenital or acquired heart
diseases.
Echocardiographic Examination
Echocardiographic and echo-Doppler examinations were per-
formed in awake dogs without sedation with commercial ultra-
sound unitsa,b equipped with diﬀerent phased-array transducers
and continuous ECG monitoring. Standard echocardiographic
scan planes were used in each dog.18 Ventricular measurements
were obtained from the right parasternal window, short axis view
by two-dimensional guided M-mode echocardiography. Measure-
ments of the left atrial (LA) and aortic diameter (Ao) were
obtained using a two-dimensional method from the right paraster-
nal short axis view at the level of the aortic root.19 The following
echocardiographic parameters were measured: left ventricular dias-
tolic diameter (LVDD), left ventricular systolic diameter (LVSD),
LA, and Ao. The diameters of the left ventricle were normalized
for the eﬀect of the body weight (BW) using the following equa-
tions: normalized LVDD (LVDDn) = LVDD/[BW0.294] and nor-
malized LVSD (LVSDn) = LVSD/[BW0.315], as previously
described.20 Other echocardiographic indices included fractional
shortening (FS), and LA:Ao.19,21 Measurements of transmitral
E-max were obtained with pulsed-wave Doppler from the left api-
cal four-chamber view.
In dogs with PH, the TRPG was calculated based on the Doppler-
derived systolic right ventricle to right atrial pressure gradient. The latter
was calculated applying the modiﬁed Bernoulli equation (Dp = 4 9
velocity2) to the TR Vmax measured from the left parasternal four-
chamber view. A peak TR Vmax ≥ 2.8 m/s (TRPG ≥ 31 mmHg) was
considered to be indicative of PH.16,17 Dogs with peak TR Vmax of
2.8–3.5 m/s, corresponding to TRPG of 31–50 mmHg, were considered
to have mild PH, dogs with peak TR Vmax of 3.6–4.3 m/s, correspond-
ing to TRPG of 51–75 mmHg, were considered to have moderate PH,
and dogs with peak TR Vmax ≥ 4.4 m/s, corresponding to TRPG ≥
76 mmHg, were considered to have severe PH.16,17
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Laboratory Evaluation
CBC and serum biochemical analyses were performed within
24 hours on blood samples collected from dogs fasted for 12 hours
beforehand. The RDW and other hematologic variables were mea-
sured by an automated CBC analyzerc previously validated for
canine hematology.2,22 Serum biochemical variables were evaluated
by a commercial analyzer.d The internal quality controls provided
by the manufacturers “Test Point Normal Control” and “Normal
and Pathologic” were run daily for hematology and clinical chem-
istry analysis, respectively. The external quality control was per-
formed for both analyzers using human control material every
weeke and following the EQA-RQAS (External Quality Assess-
ment-Randox International Quality Assessment Scheme) monthly.
Reference intervals for RDW, hematocrit, and serum urea and
creatinine concentrations, in the laboratory where the analyses
were performed, were 11.9 to 14.5%, 38 to 57%, 20 to 50 mg/dL,
and 0.5 to 1.5 mg/dL, respectively. Dogs were considered anemic
when hematocrit was ≤37%. Dogs were considered to have mild
anemia when hematocrit was ≥30 and ≤37%, and moderate-to-
severe anemia when hematocrit was ≤29%.23 Dogs were consid-
ered azotemic when the serum urea and creatinine concentrations
were >50 mg/dL and >1.5 mg/dL, respectively.
Statistical Analysis
Data are reported as median and interquartile ranges. The non-
parametric Kruskal-Wallis test was used to analyze equality of
medians among groups according to the presence and type of PH
as well as PH severity. When the factors were signiﬁcant, a posthoc
test with a Bonferroni correction was applied. For nominal data
(sex), diﬀerences were evaluated by the chi-squared test.
Associations between continuous variables and RDW were
investigated by Spearman correlation coeﬃcient. After testing for
collinearity, variables signiﬁcantly associated with RDW were
included in a multiple regression analysis performed in a stepwise
manner. The relative importance of the included variables was
assessed by order of entry into the model as well as by the change
in the model R2 (DR2).
All statistical analyses were performed with a statistical soft-
ware program.f The level of signiﬁcance was set at P < .05.
Results
Study Population
The study population included 127 dogs of various
breeds, with 65 males and 62 females. Among these, 19
dogs were clinically healthy, 50 dogs had MMVD with-
out PH, 32 dogs had PH-MMVD, and 26 dogs had pre-
capillary PH. The demographic data of each patient
group are shown in Table 1. Among the 58 dogs with
PH, 26 (19 with PH-MMVD and 7 with precapillary
PH), 20 (10 with PH-MMVD and 10 with precapillary
PH), and 12 (3 with PH-MMVD and 9 with precapil-
lary PH) dogs had mild, moderate, and severe PH,
respectively. Dogs with PH-MMVD and precapillary
PH were signiﬁcantly older compared to control dogs
(P < .001 for each comparison). Dogs with PH-MMVD
had signiﬁcantly lower BW compared to control dogs
(P < .05).
Among dogs with precapillary PH, 10 dogs had
chronic respiratory disorders (interstitial lung disease, 7
dogs; pulmonary neoplasia, 1 dog; chronic bronchitis, 1
dog; and tracheal collapse, 1 dog); 6 dogs had pulmonary
arteries parasitic disease (heartworm disease, 5 dogs;
angiostrongylosis, 1 dog); 3 dogs had suspected pul-
monary thromboembolism (PTE) because of a compati-
ble clinical presentation and a diagnosed predisposing
condition (i.e., hyperadrenocorticism, 2 dogs) or echocar-
diographic evidence of a large thrombus inside the right
pulmonary artery (1 dog). In 5 dogs, left-sided cardiac
disease was excluded but the cause of PH could not be
determined. Anemia was diagnosed in 3.1% (1 of 32) and
11.5% (3 of 26) of dogs with PH-MMVD and precapil-
lary PH, respectively, and anemia was mild in the former
and moderate/severe in the latter. Only 1 dog with ane-
mia associated with precapillary PH showed mild signs of
regenerative anemia. Azotemia was diagnosed in 24%
(12 of 50) and 57.7% (15 of 26) of dogs with PH-MMVD
and precapillary PH, respectively. Anemia associated
with azotemia was found in 3.8% (1 of 26) of dogs with
precapillary PH, but no dog with PH-MMVD had ane-
mia associated with azotemia.
Thirty-one dogs were treated before visit, and the
drugs prescribed by the attending clinician are listed in
Table 1. In particular, 16% (8 of 50), 62.5% (20 of 32),
and 11.5 (3 of 26) dogs with MMVD, PH-MMVD, and
precapillary PH, respectively, were receiving 1 or more
drugs at the moment of blood sampling.
Laboratory and Echocardiographic Variables
Laboratory and echocardiographic data of the
enrolled dogs grouped according to type or severity of
PH are shown in Tables 2 and 3, respectively. The med-
ian white blood cell number (WBC) was signiﬁcantly
higher in dogs with PH-MMVD and precapillary PH
compared to that of healthy dogs (P < .001 for both
comparisons) and dogs with MMVD (P < .01 and
P < .001, respectively); also, it was higher in dogs with
mild, moderate, and severe PH compared to that of
dogs without PH (P < .05, P < .001 and P < .001,
respectively). The median serum urea concentration of
dogs with MMVD, PH-MMVD, and precapillary PH
was signiﬁcantly higher than that of control dogs
(P < .05, P < .001 and P < .001, respectively), and the
median serum urea concentration of dogs with PH-
MMVD and precapillary PH was signiﬁcantly higher
compared to that of dogs with MMVD (P < .05 for
both comparisons). Furthermore, the median serum
urea concentration of dogs with mild, moderate, and
severe PH was signiﬁcantly higher compared to that of
dogs without PH (P < .05, P < .05, and P < .001,
respectively), and the median serum urea concentration
of dogs with severe PH was signiﬁcantly higher com-
pared to that of dogs with mild PH (P < .05).
Dogs with precapillary PH had lower LVDDn and
LVSDn compared to dogs with MMVD and PH-
MMVD (P < .001 for both variables) and to normal
dogs (P < .05), and lower LA:Ao compared to dogs
with PH-MMVD (P < .001). Dogs with precapillary
PH had also signiﬁcantly higher TR Vmax and TRPG
compared to both dogs with MMVD (P < .001 for both
variables) and dogs with PH-MMVD (P < .01 for both
variables) (Table 2).
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When dogs were grouped according to the severity of
PH (Table 3), dogs with mild PH had signiﬁcantly
higher LVDDn, LA:Ao, FS, and E-max compared to
dogs without PH (P < .01, P < .001, P < .05, and
P < .001, respectively), whereas dogs with severe PH
had signiﬁcantly lower LVDDn and LVSDn compared
Table 1. Clinical data in 127 dogs.
Healthy (n = 19) MMVD (n = 50) PH-MMVD (n = 32) Precapillary PH (n = 26) Overall P-Value
Age (years) 8.5 (7.1–10.4) 10.8 (7.0–13.4) 12.0 (11.0–14.1)*** 12.0 (10.0–14.0)*** <.001
Body weight (kg) 14.5 (9.0–28.0) 9.9 (7.8–14.1) 8.7 (7.0–10.9)* 10.5 (7.0–20.0) .028
Sex (male/female) 7/12 28/22 20/12 10/16 .15
Drugs received (n) NA P (6) ACE-I (17) ACE-I (2)
ACE-I (5) Fu (12) P (2)
Fu (4) P (7) Ma (1)
Di (4) Sp (1) F (1)
Sp (4) Si (1)
Dt (1) St (1)
MMVD, Myxomatous mitral valve disease without pulmonary hypertension; PH-MMVD, pulmonary hypertension associated with myx-
omatous mitral valve disease; PH = pulmonary hypertension; n, number of dogs; NA, not applicable; P, pimobendan; ACE-I, angiotensin-
converting enzyme inhibitor; Fu, furosemide; Di, digoxin; Sp, spironolactone; Dt, diltiazem; Ma, maropitant; Si, sildenaﬁl; St, steroids.
*P < .05 compared with healthy dogs.
**P < .01 compared with healthy dogs.
***P < .001 compared with healthy dogs.
Data are expressed as median (interquartile range).
Table 2. Laboratory and echocardiographic data in 127 dogs.
Healthy (n = 19)
MMVD
Precapillary PH (n = 26) Overall P-ValueMMVD (n = 50) PH-MMVD (n = 32)
Hematology
RDW (%) 13.3 (12.3–13.7) 13.5 (12.7–14.2) 13.7 (13.2–14.7)* 13.8 (13.2–14.9)* .011
Hematocrit (%) 48.6 (45.6–50.5) 45.5 (42.2–50.5) 48.2 (41.2–51.8) 48 (45–51.2) .58
Hemoglobin (g/dL) 168 (160–172) 157 (144–171) 164 (141–175) 162 (148–173) .81
MCV (fL) 69.2 (66.7–70.7) 68.3 (64.6–70.4) 68.2 (65.0–70.3) 68.9 (65.4–71.5) .76
WBC (109/L) 7.4 (6.2–10.5) 9.6 (7.5–11.0) 12.2 (9.3–18.1)***,†† 15.1 (10.0–25.3)***,††† <.001
Platelets (109/L) 355 (262–403) 339 (284–449) 372 (315–460) 405 (270–493) .32
Biochemistry
Urea (mg/dL) 29.0 (17.8–34.0) 38.5 (28.0–44.0)* 47.0 (37.0–81.0)***,† 59.8 (33.0–81.5)***,† <.001
Creatinine (mg/dL) 0.94 (0.76–1.07) 0.94 (0.81–1.11) 1.23 (0.85–1.42) 0.98 (0.83–1.26) .11
Total proteins (g/L) 65.7 (62.6–71.2) 61.4 (58.7–67.0) 62.1 (57.5–68.5) 69.2 (61.8–75.8) .11
Echo
LVDDn 1.54 (1.4–1.57) 1.59 (1.46–1.72) 2.16 (2.0–2.26)***,††† 1.13 (0.87–1.43)*,†††,### <.001
LVSDn 0.97 (0.93–1.00) 0.91 (0.8–1.09)* 1.1 (0.94–1.23) 0.66 (0.6–0.86)*,†††,### <.001
LA:Ao 1.30 (1.20–1.40) 1.50 (1.33–1.66)*** 2.83 (2.45–3.36)***,††† 1.38 (1.30–1.55)### <.001
FS (%) 34 (31–39) 39 (33–44) 48 (41–54)***,††† 41 (27–46) <.001
E-max (m/s) 0.70 (0.58–0.83) 0.74 (0.60–0.94) 1.62 (1.39–1.81)***,††† 0.57 (0.41–0.63)**,†††,### <.001
TR Vmax (m/s) NA 2.34 (1.92–2.62) 3.46 (3.25–3.69)††† 4.05 (3.46–4.61)†††,## <.001
TRPG (mmHg) NA 21.9 (14.7–27.4) 47.9 (40.1–54.0)††† 65.8 (47.8–85.0)†††,## <.001
RDW, Red blood cell distribution width; MCV, mean corpuscular volume; WBC, white blood cell number; LVDDn, left ventricular
diastolic diameter normalized for body weight; LVSDn, left ventricular systolic diameter normalized for body weight; LA, left atrial diame-
ter; Ao, aortic diameter; FS, fractional shortening; E-max, transmitral peak E-wave velocity; TR Vmax, peak velocity of tricuspid regurgi-
tation; TRPG, tricuspid regurgitation pressure gradient; n, number of dogs; MMVD, myxomatous mitral valve disease; PH-MMVD,
pulmonary hypertension associated with MMVD.
*P < .05 compared with healthy dogs.
**P < .01 compared with healthy dogs.
***P ≤ .001 compared with healthy dogs.
†P < .05 compared with dogs with MMVD.
††P < .01 compared with dogs with MMVD.
†††P ≤ .001 compared with dogs with MMVD.
#P < .05 compared with dogs with PH-MMVD.
##P < .01 compared with dogs with PH-MMVD.
###P ≤ .001 compared with dogs with PH-MMVD.
Data are expressed as median (interquartile range).
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to dogs with mild PH (P < .05 and P < .01, respec-
tively), and signiﬁcantly lower LVSDn and higher FS
compared to dogs without PH (P < .01 for both
comparisons).
RDW
In healthy dogs, the median (interquartile range)
RDW was 13.3% (12.3–13.7%). Seven of 50 (14%)
dogs with MMVD, 9 of 32 (28.1%) dogs with PH-
MMVD, and 8 of 26 (30.8%) dogs with precapillary
PH had RDW greater than the upper reference limit of
14.5%. In particular, dogs with precapillary PH and
increased RDW included 4 dogs with chronic respira-
tory disorders, 2 dogs with heartworm disease, and 1
dog each with PTE and indeterminate PH etiology. The
17 dogs with PH and increased RDW (9 with PH-
MMVD and 8 with precapillary PH) were quite equally
distributed among the diﬀerent PH groups, with 6 dogs
each in the mild and moderate PH group, and 5 dogs in
the severe PH group.
The median (interquartile range) of RDW in dogs
with PH-MMVD and precapillary PH was 13.7%
(13.2–14.7%) and 13.8% (13.2–14.9%), respectively,
and was signiﬁcantly higher compared to that of control
dogs (P < .05 for both comparisons). No signiﬁcant dif-
ference was found in the RDW between control dogs
and dogs with MMVD (Table 2 and Fig 1A). The med-
ian RDW in dogs with severe PH was 14.5% (13.6–
17.3%) and was signiﬁcantly higher compared to that
of dogs without PH (P < .05) (Table 3 and Fig 1B).
The RDW of dogs with mild and moderate PH was not
signiﬁcantly diﬀerent from that of dogs without PH.
Correlation and Multiple Regression Analysis
Spearman’s coeﬃcient of correlation between RDW
and demographic, laboratory, and echocardiographic
variables is shown in Table 4. The RDW was signiﬁ-
cantly positively associated with increasing age, white
blood cell number (WBC), serum urea concentration,
TR Vmax, and TRPG and signiﬁcantly negatively asso-
ciated with hematocrit and hemoglobin. Scatterplots of
RDW and the independent variables age, WBC, hemat-
ocrit, serum urea concentration, and TRPG are
depicted in Figure 2.
Table 3. Laboratory and echocardiographic data in 69 dogs without pulmonary hypertension (No PH), including
healthy dogs and dogs with myxomatous mitral valve disease without PH, and 58 dogs with diﬀerent degree of PH.
No PH (n = 69)
PH
Overall P-ValueMild (n = 26) Moderate (n = 20) Severe (n = 12)
Hematology
RDW (%) 13.4 (12.7–14.0) 13.7 (13.2–14.5) 13.5 (13.0–14.8) 14.5 (13.6–17.3)* .009
Hematocrit (%) 47.4 (44.3–50.5) 49.7 (45.0–53.0) 46.7 (40.4–51.4) 48.0 (43.4–50.2) .36
Hemoglobin (g/dL) 161 (146–171) 166 (150–177) 157 (134–173) 163 (149–172) .55
MCV (fL) 68.3 (65.5–70.6) 68.2 (66.0–70.5) 69.0 (65.3–70.9) 67.7 (64.5–69.6) .82
WBC (109/L) 8.7 (7.2–10.5) 10.6 (8.7–17.3)* 15.9 (10.2–20.4)*** 14.4 (11.7–37.0)*** <.001
Platelets (109/L) 341 (277–429) 399 (314–493) 372 (270–491) 385 (297–415) .34
Biochemistry
Urea (mg/dL) 34.0 (26.0–42.0) 44.0 (30.4–68.0)* 48.0 (35.0–83.0)* 81.5 (51.1–138.0)***,† <.001
Creatinine (mg/dL) 0.94 (0.80–1.11) 1.16 (0.85–1.31) 0.91 (0.79–1.41) 1.15 (0.91–1.44) .086
Total proteins (g/L) 64.0 (59.3–69.0) 65.7 (59.0–71.0) 62.7 (56.3–74.5) 67.0 (60.9–69.7) .75
Echo
LVDDn 1.57 (1.43–1.72) 2.03 (1.55–2.19)** 1.83 (0.96–2.15) 1.13 (0.84–1.66)† .001
LVSDn 0.93 (0.80–1.04) 1.05 (0.88–1.17) 0.77 (0.64–1.18) 0.63 (0.43–0.71)**,†† <.001
LA:Ao 1.41 (1.27–1.58) 2.45 (1.79–2.89)*** 1.94 (1.30–2.93) 1.57 (1.30–2.23) <.001
FS (%) 36 (32–42) 42 (39–48)* 45 (34–49) 52 (41–59)** .001
E-max (m/s) 0.72 (0.60–0.86) 1.38 (0.70–1.73)*** 0.97 (0.54–1.63) 0.68 (0.45–1.25) .001
TR Vmax (m/s) 2.34 (1.92–2.62)a 3.28 (3.12–3.45)*** 3.77 (3.66–4.06)***,††† 4.97 (4.57–5.28)***†††,### <.001
TRPG (mmHg) 21.9 (14.7–27.4)a 43.0 (38.9–47.6)*** 56.8  (53.4–65.8)***,††† 98.6 (83.4–111.3)***,†††,### <.001
RDW, Red blood cell distribution width; MCV, mean corpuscular volume; WBC, white blood cell number; LVDDn, left ventricular
diastolic diameter normalized for body weight; LVSDn, left ventricular systolic diameter normalized for body weight; LA, left atrial diame-
ter; Ao, aortic diameter; FS, fractional shortening; E-max, transmitral peak E-wave velocity; TR Vmax, peak velocity of tricuspid regurgi-
tation; TRPG, tricuspid regurgitation pressure gradient; n, number of dogs.
*P < .05 compared with dogs without PH.
**P ≤ .01 compared with dogs without PH.
***P < .001 compared with dogs without PH.
†P < .05 compared with dogs with mild PH.
††P < .01 compared with dogs with mild PH.
†††P < .001 compared with dogs with mild PH.
#P < .05 compared with dogs with moderate PH.
##P < .01 compared with dogs with moderate PH.
###P < .001 compared with dogs with moderate PH.
aValues obtained from 50 dogs with TR.
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To identify important contributors to RDW, multi-
variate stepwise regression models were constructed
including age, WBC, hematocrit, serum urea concentra-
tion, and TRPG as independent variables (Table 5).
Hemoglobin and TR Vmax were excluded from the
model after testing for collinearity. Based on the order
of entry, serum urea concentration had the highest
explanatory power in the model and explained about
12% of the total variation of RDW. The estimated
regression coeﬃcient was about 0.01, which means that
for every unitary increase of serum urea, RDW
increased of 0.01%. The other variables included in the
model showed an average incremental contribution of
R2 of about 6%. The ﬁnal R2 of the model was 30%.
Only hematocrit showed a negative regression coeﬃ-
cient. The variance inﬂation factors were about 1 for
every predictor which means that there was no correla-
tion among the variables. Therefore, the variance of
estimated regression coeﬃcients was not inﬂated at all.
TRPG was the only predictor not included in the
model.
Discussion
The results of the present study revealed that RDW
was increased in both dogs with PH-MMVD and dogs
with precapillary PH without concomitant changes of
MCV, but only dogs with severe PH had increased
RDW. Multivariate analyses showed that age, hemat-
ocrit, WBC, and serum urea concentration, but not
Doppler-estimated TRPG, namely PH severity, were
signiﬁcantly associated with increased RDW in the dog.
Dogs with precapillary PH had a higher value of TR
Vmax and, consequently, TRPG, compared to dogs
with PH-MMVD. These ﬁndings support that precapil-
lary PH is usually associated with a greater increase in
pulmonary arterial pressure compared to postcapillary
PH in dogs,15,24,25 although they might be the conse-
quence of a more advanced disease in dogs with precap-
illary PH. Hence, dogs with precapillary PH are often
evaluated after the onset of clinical signs, whereas dogs
with MMVD can be evaluated at diﬀerent disease
stages, even when clinical signs of PH are not present.
A
B
Fig 1. Box and whisker plots of the RDW obtained from (A) 19
healthy dogs (control), 50 dogs with myxomatous mitral valve dis-
ease without pulmonary hypertension (MMVD), 32 dogs with
postcapillary pulmonary hypertension associated with myxomatous
mitral valve disease (PH-MMVD), and 26 dogs with precapillary
pulmonary hypertension (precapillary PH) and (B) 59 dogs with-
out PH (No PH) including healthy dogs and dogs with MMVD
without PH, 26 dogs with mild PH (19 with PH-MMVD and 7
with precapillary PH), 20 dogs with moderate PH (10 with PH-
MMVD and 10 with precapillary PH), and 12 dogs with severe
PH (3 with PH-MMVD and 9 with precapillary PH). Dashed lines
indicate RDW reference interval. Outliers are plotted separately as
white dots. Median (horizontal lines), inter quartile range (boxes)
and 95% CI (whiskers) are also represented. * Statistical diﬀerence
(P < .05) with control dogs. ** Statistical diﬀerence (P < .01) with
dogs without PH.
Table 4. Spearman’s correlation coeﬃcients between
red blood cell distribution width and demographic, lab-
oratory, and echocardiographic variables in 127 dogs.
Spearman’s Correlation
Coeﬃcient P-Value
Age 0.327 <.001
Weight 0.058 .52
Hematocrit 0.225 .011
Hemoglobin 0.227 .010
MCV 0.077 .39
WBC 0.319 <.001
Platelets 0.057 .53
Urea 0.311 <.001
Creatinine 0.128 .16
Total proteins 0.068 .47
LVDDn 0.004 .96
LVSDn 0.023 .80
LA:Ao 0.163 .07
FS 0.002 .98
E-max 0.023 .80
TR Vmax 0.263 .007
TRPG 0.263 .007
MCV, Mean corpuscular volume; WBC, white blood cells num-
ber; LVDDn, left ventricular diastolic diameter normalized for
body weight; LVSDn, left ventricular systolic diameter normalized
for body weight; LA, left atrial diameter; Ao, aortic diameter; FS,
fractional shortening; E-max, transmitral peak E-wave velocity;
TR Vmax, peak velocity of tricuspid regurgitation; TRPG, tricus-
pid regurgitation pressure gradient.
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According to both inclusion criteria (i.e., increased LA
and E-max, which are echocardiographic indices associ-
ated with more severe prognosis in dogs with
MMVD)26–28 and the observed increased of left ventric-
ular dimension, dogs with PH-MMVD showed more
severe left-sided cardiac remodeling compared to dogs
with MMVD without PH, as previously reported.15,29–31
Conversely, dogs with precapillary PH had reduced left
ventricular dimension compared to dogs of all the other
groups, likely as a consequence of reduced venous
return to the left heart.25,32,33
More than one quarter and one-third of dogs with
PH-MMVD and precapillary PH had RDW greater
than the reference interval, respectively, and their med-
ian RDW was signiﬁcantly increased compared to that
of control dogs. However, only dogs with severe PH,
regardless of the underlying pathophysiologic mecha-
nism, had increased RDW compared to dogs without
PH or dogs with mild or moderate PH. Increased
RDW in dogs with precapillary PH but not in dogs
with postcapillary PH compared to healthy dogs has
been recently reported.17 Diﬀerences in study design
A B
C D
E
Fig 2. Scatterplots of the relationship between red blood cell distribution width (RDW) and (A) age, (B) hematocrit (Hct), (C) white
blood cell number (WBC), and (D) serum urea concentration in 69 dogs without pulmonary hypertension (PH) and 58 dogs with PH, and
between RDW and (E) tricuspid regurgitation pressure gradient (TRPG) in 108 dogs with tricuspid regurgitation. Dashed lines indicate
RDW reference interval.
Table 5. Multivariate regression equations showing the relationship between red blood cell distribution width and
demographic, laboratory, and echocardiographic variables in 127 dogs.
Order of Entry Variable Partial R2 Model R2 Coeﬃcient SE P-Value
Variance Inﬂation
Factor
1 Urea 0.117 0.117 0.01 0.003 <.001 1.338
2 Hematocrit 0.117 0.234 0.07 0.019 <.001 1.038
3 Age 0.039 0.273 0.086 0.04 .025 1.148
4 WBC 0.030 0.304 0.034 0.017 .044 1.219
SE, standard error; WBC, white blood cells number.
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and cardiac diseases associated with postcapillary PH
might explain diﬀerent results between this study and
that previous study. Chronic respiratory disorders,
heartworm disease, and PTE, in addition to MMVD,
were most frequently associated with increased RDW in
dogs with PH reported here. Increased RDW has been
reported as an early predictor of RV failure and an
independent negative prognostic factor in human
patients with chronic pulmonary disorders,34,35 and
acute and chronic thrombotic and thromboembolic pul-
monary disorders.7,36–39
In dogs of the present study, age was positively
associated with increased RDW in the multiple regres-
sion model. A gradual increase of RDW with aging
has been reported in the human scientiﬁc literature.40
In the dog, a recent study evidenced no signiﬁcant dif-
ference of RDW between puppies and adult dogs,41
but no information is available regarding changes of
RDW in aged dogs. RDW was negatively associated
with hematocrit and hemoglobin concentration. How-
ever, no correlation was found between RDW and
MCV, diﬀerently from previous studies both in
humans and dogs.5,8,17 The reasons of this discrepancy
remain unclear. The biologic mechanisms underlying
the association between high RDW and diﬀerent
human cardiovascular diseases including myocardial
infarction, coronary artery disease, atrial ﬁbrillation,
stroke, peripheral artery occlusive disease, and PH, as
well as other systemic disorders (e.g., cancer, diabetes,
kidney, or liver disease), are still largely
unclear.3,5,6,40,42 In people, it has not yet been well elu-
cidated whether RDW might be an independent car-
diovascular risk factor or whether it rather only
represents a simple marker of a concomitant disorder,
such as an underlying inﬂammatory state that impairs
erythrocyte maturation; impaired renal function and
consequent inadequate production of erythropoietin;
malnutrition (i.e., deﬁciencies in nutrients, such as iron,
vitamin B12, and folate); or oxidative damage.3,5,36,40,42
Inﬂammation, oxidative stress, or both have been pro-
posed as the important determinants of RDW in some
forms of PH in humans.3,6 The increased WBC con-
centration we found in dogs with PH-MMVD and pre-
capillary PH, as well as in dogs with moderate and
severe PH, and the signiﬁcant association of WBC and
RDW suggest that inﬂammation may be associated
with anisocytosis in dogs with PH. However, increased
WBC in these dogs might also represent a stress
response for the underlying disease, hospitalization, or
both43 Increased urea concentration but not creatinine
concentration was found in dogs of the present study
with PH-MMVD and precapillary PH as well as in
dogs with moderate and severe PH. Furthermore,
RDW had a signiﬁcant positive association with serum
urea but not creatinine concentration suggesting a pos-
sible relationship between RDW and prerenal azote-
mia. In humans, a strong, graded, and independent
association between RDW and estimated glomerular
ﬁltration rate has been demonstrated as well as a par-
allel increase of RDW and stages of chronic kidney
disease.44,45 However, because of the lack of urinalysis
results, we cannot draw ﬁrm conclusions about the
actual origin of azotemia in dogs of the present study.
Moreover, serum urea values could have been aﬀected
by drugs employed in some dogs at inclusion (e.g., fur-
osemide and ACE-inhibitors),46,47 but this eﬀect could
not be quantiﬁed. Other variables with a signiﬁcant
association with RDW were hematocrit and hemoglo-
bin, as well as TR Vmax and associated TRPG. How-
ever, in addition to age and hematocrit, only serum
urea concentration and WBC remained signiﬁcantly
associated with increased RDW after multivariate anal-
yses. These ﬁndings suggest that RDW is likely a mar-
ker of concomitant disorders in dogs with PH because
the association between RDW and severity of PH was
not conﬁrmed in the multivariate analyses.
Few studies have been speciﬁcally focused on cardiac
biomarkers in dogs with naturally occurring PH includ-
ing evaluation of cardiac troponin I (cTnI) and natri-
uretic peptides concentration in dogs with precapillary
PH, PH-MMVD, and experimentally induced chronic
embolic PH.14–16,48 Because of diﬀerences in study
design and patient population, some disparities exist
among results of these studies but increased levels of
cTnI and brain natriuretic peptide were observed in
dogs with precapillary PH, particularly in those with
more severe PH, PTE, or both.15,16 Although the
RDW, which is a routine part of the CBC, would be a
cost-eﬀective alternative to more expensive laboratory
evaluations, its diagnostic and prognostic utility in dogs
with PH appears limited according to the results of the
present and a recent study,17 respectively.
There were various limitations to the present study.
Healthy dogs were age-matched with dogs with
MMVD but not with dogs with PH-MMVD and pre-
capillary PH, and a positive association between RDW
and age was found in dogs of the present study. The
diagnosis of PH was based on Doppler echocardio-
graphic ﬁndings of TR Vmax, and neither cardiac
catheterization nor other echocardiographic and echo-
Doppler parameters were employed for the direct and
indirect conﬁrmation or exclusion of PH.31,49,50 Dop-
pler evaluation of TR Vmax is the most commonly
employed technique for the diagnosis of canine PH in
the clinical setting,12,13 and the presence of PH was
considered very unlikely in clinically healthy dogs with-
out clinical, radiographic, and echocardiographic evi-
dence of cardiorespiratory disorders, although a
measurable TR was not available in these dogs. Fur-
thermore, no assessment of right ventricular function
was carried out. Thus, underestimation of PH severity
in dogs with right ventricular dysfunction cannot be
excluded. Some of the dogs classiﬁed with PH-MMVD
could have concomitant undetectable chronic bronchial
or pulmonary disease. In these dogs, PH was consid-
ered postcapillary but a precapillary component cannot
be completely excluded. Dogs with precapillary PH
had higher TRPG compared to dogs with PH-MMVD,
but this probably reﬂects a diﬀerent disease stage that
could have biased the study results. Absolute reticulo-
cyte count was not available. These data would have
added additional useful information on the
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pathophysiology of the observed diﬀerence in RDW
and would have excluded confounding factors in the
small subset of anemic dogs. The diagnosis of PTE in
3 dogs with precapillary PH was based on clinical ﬁnd-
ings in dogs with predisposing disease or echocardio-
graphic evidence of a thrombus inside the pulmonary
artery. Necropsy conﬁrmation was available in only 1
case, but advanced imaging techniques (i.e., scintigra-
phy or computed tomographic angiography) were not
used in the diagnostic work. Finally, dogs with car-
diopulmonary disease included in the study were either
ﬁrst-opinion or referred cases and almost a quarter of
them were receiving drugs for the underlying disease.
The eﬀect of these drugs on each measured RDW
could not be determined.
Conclusions
A signiﬁcantly increased RDW was found in dogs
with both precapillary PH and postcapillary PH, as well
as in dogs with severe PH regardless of the underlying
pathophysiological mechanism. Results of the multivari-
ate analyses showed a positive association between
RDW and serum urea concentration and WBC count,
but not with severity of PH. Although the biologic
mechanism underlying the association between raised
RDW and PH cannot be determined from this study, it
may be associated with dehydration, a proinﬂammatory
or stressful state, or both.
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